| Literature DB >> 18345699 |
Jean-Michel Escoffre1, Arnaud Debin, Jean-Paul Reynes, Daniel Drocourt, Gérard Tiraby, Laëtitia Hellaudais, Justin Teissie, Muriel Golzio.
Abstract
RNA interference appears as a promising tool for therapeutic gene silencing. A key limit is the delivery of the siRNA. A safe approach is to use a physical method such as in vivo electropulsation with contact electrodes. Getting a long lived silencing can be better approached by using the in situ expression of shRNA. This is presently obtained by using co-electrotransfer of specific plasmids coding for expression and silencing of a fluorescent protein. Using a non invasive fluorescence imaging assay, electrodelivery in mouse muscles is observed to induce complete silencing over more than two months in a specific way. The proper choices of the plasmids (sequence and relative amounts) and of the electric pulsing conditions appear as key parameters in the successful silencing.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18345699 DOI: 10.1177/153303460800700203
Source DB: PubMed Journal: Technol Cancer Res Treat ISSN: 1533-0338